|
|
|
Search for: "Abbott"
Your search returned too many results! The most recent 500 items are shown below:
Hospira Announces CEO Succession Plan
HSMN NewsFeed,
20 Aug 2010:
Biopharmaceuticals, Personnel
[Hospira]
|
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
HSMN NewsFeed,
16 Aug 2010:
Biopharmaceuticals, Personnel
[Selecta Biosciences]
|
SonoSite Announces Non-Executive Chairman Kirby Cramer's Retirement; Dr. Robert Hauser Appointed as New Chairman
HSMN NewsFeed,
12 Aug 2010:
Devices, Personnel
[SonoSite, ultrasound]
|
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
HSMN NewsFeed,
30 Jul 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Conatus Pharmaceuticals, Idun Pharmaceuticals, Pfizer]
|
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB
HSMN NewsFeed,
29 Jul 2010:
Biopharmaceuticals, Acquisitions
[Actient Pharmaceuticals, UCB, alprostadil, theophylline, acrivastine, penbutolol]
|
Abbott's SIMCOR(R) (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
HSMN NewsFeed,
28 Jul 2010:
Biopharmaceuticals, Cardiology, FDA
[Abbott, SIMCOR, niacin, simvastatin, cholesterol]
|
HYCOR Biomedical Announces Senior Executive Appointments
HSMN NewsFeed,
22 Jul 2010:
Diagnostics, Personnel
[HYCOR Biomedical]
|
AcuFocus Names Ophthalmic Sales Veteran Mike Judy as Chief Commercialization Officer
HSMN NewsFeed,
20 Jul 2010:
Devices, Ophthalmology, Personnel
[AcuFocus]
|
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
HSMN NewsFeed,
20 Jul 2010:
Biopharmaceuticals, Personnel
[Seaside Therapeutics]
|
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
HSMN NewsFeed,
19 Jul 2010:
Biopharmaceuticals, HIV/AIDS
[Abbott, protease inhibitor, Kaletra, PROGRESS study]
|
Olivier Bohuon Joins Pierre Fabre
HSMN NewsFeed,
2 Jul 2010:
Biopharmaceuticals, Personnel
[Pierre Fabre]
|
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
HSMN NewsFeed,
28 Jun 2010:
Diagnostics, FDA
[Abbott, gonorrhea, chlamydia, Abbott m2000]
|
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
HSMN NewsFeed,
21 Jun 2010:
Diagnostics, HIV/AIDS, FDA
[Abbott, Abbott ARCHITECT, HIV Ag/Ab]
|
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
HSMN NewsFeed,
16 Jun 2010:
Biopharmaceuticals, Personnel
[Eurand]
|
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
HSMN NewsFeed,
16 Jun 2010:
Biopharmaceuticals
[Abbott, Neurocrine Biosciences, elagolix, endometriosis, uterine fibroids]
|
Abbott Receives FDA Clearance for New Ovarian Cancer Test
HSMN NewsFeed,
3 Jun 2010:
Diagnostics, Oncology, FDA
[Abbott, human epididymis protein, ovarian cancer]
|
CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation Testing System for Patient Home Use
HSMN NewsFeed,
1 Jun 2010:
Devices, Diagnostics, Monitoring, FDA
[CoaguSense, Prothrombin Time, Coumadin, warfarin]
|
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
HSMN NewsFeed,
26 May 2010:
Devices, Interventional
[Abbott, ACCULINK, Carotid Stent, ACCUNET, Embolic Protection, Endarterectomy]
|
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
HSMN NewsFeed,
26 May 2010:
Biopharmaceuticals, Venture Capital
[Alvine Pharmaceuticals, Celiac Disease]
|
Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology
HSMN NewsFeed,
26 May 2010:
Devices, Interventional Cardiology, Regulatory
[Abbott, TREK Coronary Dilatation Catheter, TREK system]
|
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
HSMN NewsFeed,
26 May 2010:
Devices, Interventional Cardiology
[Boston Scientific, PLATINUM PLUS, PROMUS Element, Everolimus, drug eluting stent]
|
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
HSMN NewsFeed,
25 May 2010:
Devices, Interventional Cardiology
[Abbott, bioresorbable vascular scaffold, everolimus]
|
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
HSMN NewsFeed,
25 May 2010:
Devices, Interventional Cardiology
[Medtronic, Resolute zotarolimus-eluting stent, drug eluting stent]
|
Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
HSMN NewsFeed,
25 May 2010:
Devices, Cardiology
[Abbott, EVEREST II, MitraClip, mitral regurgitation]
|
Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
HSMN NewsFeed,
21 May 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Piramal]
|
Boston Scientific Announces Schedule for EuroPCR 2010
HSMN NewsFeed,
20 May 2010:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS, PROMUS , drug eluting stent]
|
Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease
HSMN NewsFeed,
19 May 2010:
Diagnostics, FDA
[Abbott, PRISM Chagas test, kissing bug]
|
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
HSMN NewsFeed,
17 May 2010:
Regenerative Medicine, Interventional Cardiology
[Aastrom Biosciences, dilated cardiomyopathy, tissue repair cells]
|
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
HSMN NewsFeed,
14 May 2010:
Biopharmaceuticals, Personnel
[Epizyme, epigenetics, histone methyltransferase]
|
Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division
HSMN NewsFeed,
11 May 2010:
Biopharmaceuticals, Licensing
[Abbott, Zydus Cadila]
|
MitraClip Safely Relieves Symptoms in Patients With No Surgical Options
HSMN NewsFeed,
6 May 2010:
Devices, Interventional Cardiology
[SCAI, Evalve , Abbott, EVEREST II, MitraClip, mitral regurgitation]
|
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
HSMN NewsFeed,
5 May 2010:
Devices, Interventional Cardiology
[Abbott, XIENCE, Everolimus, Drug Eluting Stent, TAXUS]
|
Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, FDA
[Abbott, CREON , pancrelipase, pancreatitis]
|
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, Personnel
[VIVUS]
|
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra(R) (lopinavir / ritonavir) for Treatment-Experienced Patients
HSMN NewsFeed,
28 Apr 2010:
Biopharmaceuticals, HIV/AIDS, FDA
[Abbott, Kaletra, lopinavir, ritonavir]
|
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
HSMN NewsFeed,
13 Apr 2010:
Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]
|
First Comprehensive LASIK Treatment of Astigmatism Approved by the FDA
HSMN NewsFeed,
10 Apr 2010:
Devices, Ophthalmology, FDA
[Technolas Perfect Vision, Advanced Control Eyetracking, LASIK, astigmatism]
|
Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development
HSMN NewsFeed,
7 Apr 2010:
Biopharmaceuticals, Drug Delivery, Personnel
[Tris Pharma, OralXR+]
|
AcelRx Pharmaceuticals Names Richard King Chief Executive Officer
HSMN NewsFeed,
6 Apr 2010:
Biopharmaceuticals, Drug Delivery, Personnel
[AcelRx Pharmaceuticals, NanoTab]
|
Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury
HSMN NewsFeed,
31 Mar 2010:
Diagnostics, FDA
[Abbott, neutrophil gelatinase-associated lipocalin, acute kidney injury]
|
AstraZeneca and Abbott Receive FDA Complete Response Letter on CERTRIAD(TM) New Drug Application
HSMN NewsFeed,
30 Mar 2010:
Biopharmaceuticals, FDA
[Abbott, AstraZeneca, CERTRIAD]
|
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
HSMN NewsFeed,
10 Mar 2010:
Devices, Ophthalmology, FDA
[Abbott, TECNIS, Multifocal intraocular lens, intraocular lens]
|
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
HSMN NewsFeed,
3 Mar 2010:
Diagnostics, Biopharmaceuticals, Oncology
[Abbott, GlaxoSmithKline, Immunotherapy, melanoma]
|
NMT Medical Appoints John E. Ahern to Board of Directors
HSMN NewsFeed,
3 Mar 2010:
Devices, Interventional Cardiology, Personnel
[NMT Medical, patent foramen ovale, PFO closure]
|
NovoStent Receives CE Mark for New Class of Endovascular Implant
HSMN NewsFeed,
1 Mar 2010:
Devices, Interventional, Regulatory
[NovoStent, SAMBA stent, SAMBA trial, peripheral arterial disease]
|
Inspire Names Adrian Adams as President and Chief Executive Officer
HSMN NewsFeed,
19 Feb 2010:
Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]
|
Abbott Completes Acquisition of Solvay Pharmaceuticals
HSMN NewsFeed,
16 Feb 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Solvay Pharmaceuticals]
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
HSMN NewsFeed,
11 Feb 2010:
Biopharmaceuticals, HIV/AIDS, FDA
[Abbott, Norvir, ritonavir, Kaletra, lopinavir]
|
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
HSMN NewsFeed,
8 Feb 2010:
Diagnostics, Oncology, FDA
[Abbott, ARCHITECT HE4, HE4, ovarian cancer]
|
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
HSMN NewsFeed,
29 Jan 2010:
Biopharmaceuticals, Neurology, FDA
[GlaxoSmithKline, Lamictal, Lamictal XR, lamotrigine, epilepsy]
|
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
HSMN NewsFeed,
26 Jan 2010:
Biopharmaceuticals, Neurology, Personnel
[Afferent Pharmaceuticals]
|
Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemia
HSMN NewsFeed,
22 Jan 2010:
Biopharmaceuticals, Oncology, Regulatory
[Genmab, Arzerra, ofatumumab, GlaxoSmithKline, chronic lymphocytic leukemia]
|
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
HSMN NewsFeed,
14 Jan 2010:
Diagnostics, Regulatory, Oncology
[Abbott, ARCHITECT systems, HE4 test]
|
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed,
13 Jan 2010:
Devices, Venture Capital
[The Foundry]
|
Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
HSMN NewsFeed,
8 Jan 2010:
Devices, Interventional Cardiology, Regulatory
[Boston Scientific, PROMUS, Everolimus, drug eluting stent]
|
ArthroCare Names Scott Schaffner Senior Vice President and General Manager of Sports Medicine
HSMN NewsFeed,
4 Jan 2010:
Devices, Personnel
[ArthroCare]
|
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
HSMN NewsFeed,
10 Dec 2009:
Biopharmaceuticals, Personnel
[Lundbeck]
|
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
HSMN NewsFeed,
23 Nov 2009:
Biopharmaceuticals, Personnel
[Orexigen Therapeutics]
|
Abbott to Develop New Heart Failure Test on ARCHITECT(R) Immunochemistry Diagnostics Platform
HSMN NewsFeed,
17 Nov 2009:
Diagnostics, Cardiology
[Abbott, BG Medicine, immunochemistry, galectin-3, heart failure]
|
XOMA Appoints Jim Neal Vice President of Business Development
HSMN NewsFeed,
17 Nov 2009:
Biopharmaceuticals, Personnel
[XOMA]
|
Watson Names Robert A. Stewart Senior Vice President, Global Operations
HSMN NewsFeed,
16 Nov 2009:
Biopharmaceuticals, Personnel
[Watson Pharmaceuticals]
|
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
HSMN NewsFeed,
12 Nov 2009:
Biopharmaceuticals, Acquisitions
[Abbott, PanGenetics, Nerve Growth Factor]
|
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
HSMN NewsFeed,
9 Nov 2009:
Devices, Interventional
[Atrium Medical, Flexible Stenting Solutions, Invatec, Ardian, W. L. Gore]
|
Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
HSMN NewsFeed,
5 Nov 2009:
Devices, Cardiology, Monitoring, Personnel
[Cardiac Science, automated external defibrillator]
|
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
HSMN NewsFeed,
20 Oct 2009:
Diagnostics, FDA
[Abbott, cyclic-citrulinated peptide, rheumatoid arthritis]
|
Abbott to Acquire Solvay Pharmaceuticals Business
HSMN NewsFeed,
28 Sep 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Solvay Pharmaceuticals]
|
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
HSMN NewsFeed,
24 Sep 2009:
Devices, Interventional Cardiology
[Volcano, vulnerable plaque, PROSPECT study, atherosclerosis, IVUS]
|
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
HSMN NewsFeed,
24 Sep 2009:
Devices, Cardiology
[Abbott, vulnerable plaque, PROSPECT study, atherosclerosis]
|
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
HSMN NewsFeed,
23 Sep 2009:
Devices, Interventional Cardiology
[Abbott, SPIRIT IV trial, XIENCE V, drug eluting stent]
|
Coherex Medical Signs Exclusive Distribution Agreement with Abbott
HSMN NewsFeed,
22 Sep 2009:
Devices, Interventional Cardiology, Distribution
[Coherex Medical, Abbott, FlatStent, Patent Foramen Ovale]
|
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
HSMN NewsFeed,
21 Sep 2009:
Diagnostics, HIV/AIDS, FDA
[Abbott, PRISM HIV O Plus, HIV-1/HIV-2]
|
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
HSMN NewsFeed,
14 Sep 2009:
Devices, Interventional Cardiology, Regulatory
[Abbott, XIENCE V, Everolimus, drug eluting stent]
|
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
HSMN NewsFeed,
10 Sep 2009:
Devices, Interventional Cardiology, Mergers & Acquisitions
[Abbott, Evalve, MitraClip, valve repair, mitral valve]
|
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
HSMN NewsFeed,
31 Aug 2009:
Devices, Interventional Cardiology
[Abbott, XIENCE PRIME, drug eluting stent]
|
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
HSMN NewsFeed,
24 Aug 2009:
Devices, Interventional Cardiology, Regulatory
[Abbott, XIENCE V, Everolimus, drug eluting stent]
|
Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
HSMN NewsFeed,
18 Aug 2009:
Biopharmaceuticals, Drug Delivery
[Abbott, Velcera, meloxicam, Promist , transmucosal]
|
Insulet Appoints Peter J. Devlin as Chief Commercial Officer
HSMN NewsFeed,
17 Aug 2009:
Devices, Endocrinology, Personnel
[Insulet, insulin pump, OmniPod]
|
Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
HSMN NewsFeed,
13 Aug 2009:
Devices, Interventional Cardiology
[Abbott, XIENCE V, Everolimus, drug eluting stent, anti-platelet]
|
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
HSMN NewsFeed,
29 Jul 2009:
Biopharmaceuticals, Personnel
[Marinus Pharmaceuticals]
|
Abbott Issues Voluntary Recall of POWERSAIL(R) Coronary Dilatation Catheters
HSMN NewsFeed,
28 Jul 2009:
Devices, Interventional Cardiology, Product Recall
[Abbott, POWERSAIL, Coronary Dilatation Catheter, balloon catheter]
|
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
HSMN NewsFeed,
27 Jul 2009:
Devices, Interventional Cardiology, Litigation
[Medtronic, Abbott, coronary stent, evYsio, drug eluting stent]
|
Accuray Announces CyberKnife Access Remote Service Product
HSMN NewsFeed,
26 Jul 2009:
Devices, Oncology
[Accuray, CyberKnife, CyberKnife Access, Axeda, radiosurgery, radiotherapy]
|
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
HSMN NewsFeed,
24 Jul 2009:
Diagnostics, Oncology
[NeoGenomics, Abbott, fluorescence in situ hybridization, melanoma]
|
Pioneer Surgical Technology, Inc. Names Thomas J. McLeer as Chief Marketing Officer and General Manager of Spinal Operations
HSMN NewsFeed,
10 Jul 2009:
Devices, Neurosurgery, Orthopaedic, Personnel
[Pioneer Surgical Technology]
|
Richard A. Meier Appointed to STAAR Surgical Board of Directors
HSMN NewsFeed,
25 Jun 2009:
Devices, Ophthalmology, Personnel
[STAAR Surgical]
|
Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
HSMN NewsFeed,
23 Jun 2009:
Devices, Interventional Cardiology, Regulatory
[Abbott, XIENCE PRIME, XIENCE, drug eluting stent]
|
WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
HSMN NewsFeed,
22 Jun 2009:
Biopharmaceuticals, Personnel
[WuXi PharmaTech]
|
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
HSMN NewsFeed,
16 Jun 2009:
Devices, Interventional Cardiology
[Abbott, SPIRIT PRIME, XIENCE PRIME, XIENCE V, drug eluting stent]
|
Abbott Announces Launch of Next-Generation Embolic Protection System
HSMN NewsFeed,
12 Jun 2009:
Devices, Interventional
[Abbott, Emboshield, Embolic Protection, carotid artery, carotid stent]
|
Lannett Company Names Terence D. Vollrath Executive Vice President
HSMN NewsFeed,
9 Jun 2009:
Biopharmaceuticals, Generics, Personnel
[Lannett Company]
|
Abbott's TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
HSMN NewsFeed,
8 Jun 2009:
Biopharmaceuticals, Endocrinology, Cardiology
[Abbott, TRILIPIX, fenofibric acid, rosuvastatin, dyslipidemia]
|
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
HSMN NewsFeed,
4 Jun 2009:
Biopharmaceuticals
[Abbott, AstraZeneca, TRILIPIX, fenofibric acid]
|
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
HSMN NewsFeed,
4 Jun 2009:
Biopharmaceuticals
[Abbott, AstraZeneca, mixed dyslipidemia, CERTRIAD]
|
Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
HSMN NewsFeed,
2 Jun 2009:
Diagnostics, Distribution
[BioGenex, Abbott, Xmatrx]
|
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
HSMN NewsFeed,
1 Jun 2009:
Biopharmaceuticals, Neurology, FDA
[GlaxoSmithKline, Lamictal, lamotrigine, epilepsy]
|
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
HSMN NewsFeed,
21 May 2009:
Devices, Interventional Cardiology
[Abbott, XIENCE V, SPIRIT V, drug eluting stent]
|
Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
HSMN NewsFeed,
20 May 2009:
Biopharmaceuticals
[Genzyme, Isis Pharmaceuticals, mipomersen]
|
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
HSMN NewsFeed,
19 May 2009:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS Element, drug eluting stent]
|
Boston Scientific Announces Schedule for EuroPCR 2009
HSMN NewsFeed,
15 May 2009:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS, drug eluting stent]
|
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed,
13 May 2009:
Biopharmaceuticals, Personnel
[Follica]
|
Enrollment Complete in the XCELL Trial - The First U.S. Study of Stent Placement to Study Arterial Blockages Below the Knee
HSMN NewsFeed,
12 May 2009:
Devices, Interventional
[Abbott Vascular, nitinol stent, Self-expanding stent]
|
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
HSMN NewsFeed,
11 May 2009:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS, Liberte, drug eluting stent]
|
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
HSMN NewsFeed,
11 May 2009:
Biopharmaceuticals, Drug Delivery, FDA
[GlaxoSmithKline, Eurand, Lamictal ODT, lamotrigine]
|
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
HSMN NewsFeed,
11 May 2009:
Biopharmaceuticals, Drug Delivery, FDA
[Eurand, GlaxoSmithKline, EUR-1048, Lamictal ODT, lamotrigine]
|
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
HSMN NewsFeed,
7 May 2009:
Biopharmaceuticals, Licensing
[Cornerstone Therapeutics, Chiesi Farmaceutici, Curosurf]
|
Takeda Global Research & Development Center, Inc., U.S. Names Dr. Azmi Nabulsi President
HSMN NewsFeed,
5 May 2009:
Biopharmaceuticals, Personnel
[Takeda Pharmaceutical, Takeda Global Research & Development]
|
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
HSMN NewsFeed,
23 Apr 2009:
Diagnostics, Licensing
[Celera Corp, Perlegen Sciences]
|
Ventus Medical Appoints John McCutcheon as President and CEO
HSMN NewsFeed,
9 Apr 2009:
Devices, Personnel
[Ventus Medical, PROVENT Therapy]
|
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
HSMN NewsFeed,
2 Apr 2009:
Biopharmaceuticals, Personnel
[RXi Pharmaceuticals]
|
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
HSMN NewsFeed,
1 Apr 2009:
Devices, Interventional
[Abbott, Absolute Pro, MOBILITY trial, PAD , Peripheral Stent]
|
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
HSMN NewsFeed,
29 Mar 2009:
Biopharmaceuticals
[Abbott, TRILIPIX, fenofibric acid, rosuvastatin]
|
Boston Scientific Announces Schedule For ACC 2009
HSMN NewsFeed,
26 Mar 2009:
Devices, Interventional Cardiology
[Boston Scientific, American College of Cardiology, drug eluting stent]
|
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
HSMN NewsFeed,
24 Mar 2009:
Devices, Interventional Cardiology
[Abbott, ABSORB trial, bioabsorbable, drug eluting stent]
|
American Medical Systems Announces New General Manager of BPH Therapy Business
HSMN NewsFeed,
24 Mar 2009:
Devices, Personnel
[American Medical Systems]
|
ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
HSMN NewsFeed,
23 Mar 2009:
Devices, Personnel
[ConvaTec]
|
Skyepharma PLC Announces Regulatory Application
HSMN NewsFeed,
23 Mar 2009:
Biopharmaceuticals, FDA
[Skyepharma, Flutiform, fluticasone, formoterol, asthma]
|
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
HSMN NewsFeed,
12 Mar 2009:
Devices, Interventional Cardiology
[Abbott, bioabsorbable drug eluting stent, drug eluting stent]
|
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
HSMN NewsFeed,
12 Mar 2009:
Biopharmaceuticals, Generics, FDA, HIV/AIDS
[Mylan, Matrix Laboratories Limited, Lopinavir/Ritonavir, Abbott, Kaletra]
|
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
HSMN NewsFeed,
10 Mar 2009:
Devices, Interventional Cardiology
[Abbott, VOYAGER NC, dilatation catheter]
|
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
HSMN NewsFeed,
2 Mar 2009:
Biopharmaceuticals, Personnel
[Pearl Therapeutics]
|
Hospitals, Healthcare Providers to Save with New Premier Agreements for Feeding Pumps, Sets, Devices and Tubing
HSMN NewsFeed,
27 Feb 2009:
Devices, Group Purchasing
[Premier Purchasing, Kimberly-Clark, Abbott Nutrition, Baxa Corp, Covidien]
|
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
HSMN NewsFeed,
27 Feb 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Arana Therapeutics]
|
Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
HSMN NewsFeed,
20 Feb 2009:
Devices, Ophthalmology, Mergers & Acquisitions
[Abbott, Advanced Medical Optics]
|
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
HSMN NewsFeed,
12 Feb 2009:
Regenerative Medicine, Cardiology
[Osiris Therapeutics, Prochymal, stem cell]
|
Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
HSMN NewsFeed,
11 Feb 2009:
Diagnostics, FDA
[Abbott, CELL-DYN Emerald]
|
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
HSMN NewsFeed,
10 Feb 2009:
Devices, Interventional Cardiology, Neurology, Personnel
[NMT Medical, patent foramen ovale, stroke]
|
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
HSMN NewsFeed,
5 Feb 2009:
Devices, Interventional Cardiology, Group Purchasing
[Premier Purchasing, Abbott, Abbott Vascular, Cordis, drug eluting stent]
|
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
HSMN NewsFeed,
5 Feb 2009:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS Liberte Atom, TAXUS Liberte Long, drug eluting stent]
|
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
HSMN NewsFeed,
5 Feb 2009:
Biopharmaceuticals, Generics, FDA
[Dr. Reddy's Laboratories, Levetiracetam, Omeprazole, Lamotragine, Divalproex]
|
Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
HSMN NewsFeed,
30 Jan 2009:
Biopharmacueticals, Generics, FDA
[Mylan, Mylan Pharmaceuticals, Divalproex, Abbott, Depakote]
|
Medtronic and Boston Scientific Reach Agreement on Patent Cases
HSMN NewsFeed,
27 Jan 2009:
Devices, Interventional Cardiology, Litigation
[Medtronic, Boston Scientific, endovascular repair]
|
Boston Scientific and Medtronic Reach Agreement on Patent Disputes
HSMN NewsFeed,
27 Jan 2009:
Devices, Interventional Cardiology, Litigation
[Boston Scientific, Medtronic, endovascular repair]
|
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott s Architect(R) Analyzers
HSMN NewsFeed,
27 Jan 2009:
Diagnostics, Oncology
[Fujirebio Diagnostics, Abbott, HE4 biomarker, ovarian cancer]
|
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
HSMN NewsFeed,
26 Jan 2009:
Devices, Interventional Cardiology
[Abbott, XIENCE, Everolimus, Drug Eluting Stent, Coronary Stent]
|
Halo Pharmaceutical Welcomes Al Rosenston as its Vice President, Business Development
HSMN NewsFeed,
26 Jan 2009:
Biopharmaceuticals, Personnel
[Halo Pharmaceutical]
|
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
HSMN NewsFeed,
20 Jan 2009:
Biopharmaceuticals, Personnel
[NovaBay Pharmaceuticals]
|
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
HSMN NewsFeed,
20 Jan 2009:
Diagnostics, Personnel
[Quidel]
|
Abbott Opens New Pharmaceutical Research Laboratory in Singapore
HSMN NewsFeed,
20 Jan 2009:
Biopharmaceuticals
[Abbott]
|
Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer
HSMN NewsFeed,
19 Jan 2009:
Devices, Diagnostics
[Abbott, i-STAT, handheld blood analyzer]
|
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
HSMN NewsFeed,
13 Jan 2009:
Diagnostics
[Abbott, RealTime High Risk HPV assay, human papillomavirus]
|
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
HSMN NewsFeed,
12 Jan 2009:
Devices, Ophthalmology, Acquisitions
[Abbott, Advanced Medical Optics]
|
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed,
8 Jan 2009:
Biopharmaceuticals, Neurology, Venture Capital, Personnel
[Satori Pharmaceuticals, Alzheimer's disease, Parkinson's disease]
|
Horizon Therapeutics Announces Senior Management Appointments
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Personnel
[Horizon Therapeutics]
|
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
HSMN NewsFeed,
17 Dec 2008:
Devices, Interventional Cardiology
[Abbott, XIENCE V, XIENCE NANO, SPIRIT Small Vessel trial]
|
Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
HSMN NewsFeed,
15 Dec 2008:
Biopharmaceuticals, FDA
[Abbott, TRILIPIX, fenofibric acid]
|
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
HSMN NewsFeed,
11 Dec 2008:
Biopharmaceuticals, Personnel
[Cornerstone Therapeutics]
|
OraSure Technologies to Sell OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Directly to U.S. Hospitals
HSMN NewsFeed,
5 Nov 2008:
Diagnostics
[OraSure Technologies, OraQuick ADVANCE, Rapid HIV-1/2]
|
Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
HSMN NewsFeed,
29 Oct 2008:
Biopharmaceuticals, Personnel
[Cornerstone Therapeutics]
|
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
HSMN NewsFeed,
28 Oct 2008:
Diagnostics, Oncology, FDA
[Ikonisys, oncoFISH her2, HER2, breast cancer]
|
Hospitals, Healthcare Providers to Save with Premier Vascular Closure Devices Agreements
HSMN NewsFeed,
21 Oct 2008:
Devices, Group Purchasing
[Premier Purchasing, Abbott Vascular, Cardiva Medical]
|
Abbott's HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn's Disease
HSMN NewsFeed,
21 Oct 2008:
Biopharmaceuticals, Gastroenterology
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Zimmer Holdings Announces Completion of Abbott Spine Acquisition
HSMN NewsFeed,
16 Oct 2008:
Devices, Orthopaedic, Neurosurgery, Acquisitions
[Zimmer Holdings, Abbott Spine, Pedicle Screw]
|
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
HSMN NewsFeed,
13 Oct 2008:
Devices, Interventional Cardiology
[Abbott, SPIRIT II, SPIRIT III, XIENCE V, drug eluting stent]
|
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
HSMN NewsFeed,
13 Oct 2008:
Devices, Interventional Cardiology
[Abbott, bioabsorbable drug eluting stent, ABSORB trial]
|
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed,
13 Oct 2008:
Biopharmaceuticals, Personnel
[Antares Pharma]
|
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
HSMN NewsFeed,
10 Oct 2008:
Devices, Interventional Cardiology, FDA
[Boston Scientific, TAXUS Liberte, drug eluting stent]
|
Hospitals, Healthcare Providers to Save with Premier Agreements for Hemostasis and Compression Products
HSMN NewsFeed,
9 Oct 2008:
Devices, Cardiology, Group Purchasing
[Premier Purchasing, Abbott, TZ Medical]
|
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
HSMN NewsFeed,
8 Oct 2008:
Devices, Personnel
[Apieron]
|
Odyssey Thera Announces New Equity Financing
HSMN NewsFeed,
7 Oct 2008:
Biopharmaceuticals, Venture Capital
[Odyssey Thera]
|
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C
HSMN NewsFeed,
6 Oct 2008:
Biopharmaceuticasl, Venture Capital
[Biolex Therapeutics]
|
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
HSMN NewsFeed,
1 Oct 2008:
Biopharmaceuticals
[Advanced Life Sciences Holdings, Wyeth Pharmaceuticals, cethromycin]
|
IVAX Diagnostics Announces Appointment of Paul F. Kennedy as Chief Executive Officer, President and Chairman of the Board
HSMN NewsFeed,
25 Sep 2008:
Diagnostics, Personnel
[IVAX Diagnostics]
|
ImaRx Therapeutics Divests Urokinase Franchise to Microbix Biosystems
HSMN NewsFeed,
24 Sep 2008:
Biopharmaceuticals, Acquisitions
[ImaRx Therapeutics, Microbix Biosystems, urokinase]
|
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Dermatology
[Abbott, HUMIRA, adalimumab, psoriasis]
|
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
HSMN NewsFeed,
15 Sep 2008:
Devices, Interventional Cardiology
[Medtronic, Endeavor Resolute, drug eluting stent]
|
Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated by Aspirin Therapy
HSMN NewsFeed,
9 Sep 2008:
Cardiology
[Celera Corp, LPA gene, Womens Health Study, aspirin therapy]
|
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
HSMN NewsFeed,
8 Sep 2008:
Devices, Endocrinology
[Medtronic, Continuous Glucose Monitoring, MiniMed Paradigm, diabetes]
|
Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
HSMN NewsFeed,
4 Sep 2008:
Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions
[Zimmer Holdings, Abbott Spine]
|
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
HSMN NewsFeed,
4 Sep 2008:
Devices, Venture Capital
[Microfabrica Inc]
|
Ipsogen SA Consolidates its Position in North America and Appoints Susan Hertzberg President, Ipsogen Inc
HSMN NewsFeed,
3 Sep 2008:
Diagnostics, Personnel
[Ipsogen]
|
Monoclonal Antibody Sales to Almost Double in Coming Years
HSMN NewsFeed,
30 Aug 2008:
Biopharmaceuticals
[Monoclonal Antibody]
|
AngioScore Submits Citizen Petition Requesting FDA Action to Deny Patent Term Extension Based on Abbott Angioplasty Catheter
HSMN NewsFeed,
25 Aug 2008:
Devices, Interventional Cardiology
[AngioScore, Abbott]
|
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
HSMN NewsFeed,
20 Aug 2008:
Biopharmaceuticals, Personnel
[Biovail]
|
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
HSMN NewsFeed,
14 Aug 2008:
Biopharmaceuticals
[Abbott, AstraZeneca, CRESTOR, rosuvastatin]
|
Follica Announces $11M in New Financing and Expanded Team
HSMN NewsFeed,
12 Aug 2008:
Devices, Personnel, Venture Capital
[Follica]
|
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, HIV/AIDS
[Abbott, Kaletra]
|
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
HSMN NewsFeed,
30 Jul 2008:
Biopharmaceuticals, Personnel
[Oscient Pharmaceuticals]
|
Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches
HSMN NewsFeed,
30 Jul 2008:
Biopharmaceuticals, FDA
[Noven Pharmaceuticals, Stavzor, valproic acid, Banner Pharmacaps]
|
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
HSMN NewsFeed,
30 Jul 2008:
Biopharmaceuticals, Drug Delivery, FDA
[Banner Pharmacaps, Valproic Acid, Stavzor, Noven Pharmaceuticals]
|
Osiris Therapeutics Appoints Chief Financial Officer
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Regenerative Medicine, Personnel
[Osiris Therapeutics, stem cell]
|
PolyMedix Appoints Two New Directors
HSMN NewsFeed,
25 Jul 2008:
Biopharmaceuticals, Personnel
[PolyMedix]
|
Horizon Therapeutics Names Timothy P. Walbert as President and CEO
HSMN NewsFeed,
24 Jul 2008:
Biopharmaceuticals, Personnel
[Horizon Therapeutics]
|
BG Medicine Closes $40 Million in Series D Financing
HSMN NewsFeed,
17 Jul 2008:
Diagnostics, Venture Capital
[BG Medicine]
|
XenoPort Appoints David A. Stamler, M.D., as Chief Medical Officer
HSMN NewsFeed,
15 Jul 2008:
Biopharmaceuticals, Personnel
[XenoPort]
|
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Personnel
[Royalty Pharma]
|
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed,
7 Jul 2008:
Biopharmaceuticals, Drug Delivery, Personnel
[Antares Pharma]
|
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
HSMN NewsFeed,
3 Jul 2008:
Devices, Interventional Cardiology, FDA
[Abbott, XIENCE, Everolimus, Drug Eluting Stent, coronary stent]
|
Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[Isis Pharmaceuticals, Ibis Biosciences, Abbott, Ibis T5000]
|
Genaera Corporation Elects Paul K. Wotton to Board of Directors
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Genaera Corp]
|
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
HSMN NewsFeed,
26 Jun 2008:
Biopharmaceuticals, Personnel
[MDS Pharma Services]
|
NICE Recommends Abbott's Adalimumab (HUMIRA(R)) for the Treatment of Chronic Plaque Psoriasis
HSMN NewsFeed,
24 Jun 2008:
Biopharmaceuticals, Dermatology, Regulatory
[Abbott, adalimumab, HUMIRA, psoriasis]
|
Santaris Pharma Appoints S0ren Tulstrup as New President & CEO
HSMN NewsFeed,
18 Jun 2008:
Biopharmaceuticals, Personnel
[Santaris Pharma]
|
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab, ankylosing spondylitis]
|
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab, rheumatoid arthritis]
|
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
HSMN NewsFeed,
13 Jun 2008:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab, rheumatoid arthritis]
|
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
9 Jun 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
HSMN NewsFeed,
3 Jun 2008:
Biopharmaceuticals, HIV/AIDS
[Abbott, Aluvia, lopinavir, ritonavir, protease inhibitor]
|
Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
HSMN NewsFeed,
2 Jun 2008:
Devices, Interventional Cardiology, Regulatory
[Abbott, XIENCE, Everolimus, Drug Eluting Stent]
|
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
HSMN NewsFeed,
31 May 2008:
Biopharmaceuticals, Cardiology
[Abbott, TriLipix, ABT-335, AstraZeneca, CRESTOR, rosuvastatin]
|
Biogen Idec Names Hans Peter Hasler Chief Operating Officer
HSMN NewsFeed,
29 May 2008:
Biopharmaceuticals, Personnel
[Biogen Idec]
|
MonoSol Rx Appoints John McCracken Senior Vice President Business Development
HSMN NewsFeed,
28 May 2008:
Biopharmaceuticals, Drug Delivery, Personnel
[MonoSol Rx, thin film pharmaceutical]
|
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
HSMN NewsFeed,
21 May 2008:
Biopharmaceuticals, Gastroenterology
[Abbott, HUMIRA, adalimumab, CHARM Trial, GAIN Trial, Crohn's disease]
|
CONMED Corporation Appoints Joseph Darling President of the CONMED Linvatec Orthopedic Products Unit
HSMN NewsFeed,
21 May 2008:
Devices, Orthopaedic, Personnel
[CONMED, CONMED Linvatec]
|
Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
HSMN NewsFeed,
16 May 2008:
Devices, Interventional
[Abbott, StarClose SE, Vascular Closure System]
|
New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus
HSMN NewsFeed,
15 May 2008:
Devices, Gastroenterology
[BARRX Medical, HALO360, Barrett's esophagus]
|
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
HSMN NewsFeed,
15 May 2008:
Biopharmaceuticals, Personnel
[Human Genome Sciences]
|
XIENCE(TM) V Drug Eluting Stent from Abbott Reduces Major Adverse Cardiac Events in Small Vessel Patients Out to One Year
HSMN NewsFeed,
14 May 2008:
Devices, Interventional Cardiology
[Abbott, XIENCE V, SPIRIT II, SPIRIT III, drug eluting stent]
|
Myocor, Inc. Implants First iCoapsys Device
HSMN NewsFeed,
13 May 2008:
Devices, Interventional Cardiology
[Myocor, iCoapsys, VIVID study, mitral regurgitation, Reshaping Therapy]
|
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
HSMN NewsFeed,
13 May 2008:
Devices, Interventional Cardiology
[Boston Scientific, SPIRIT III, TAXUS Express2, XIENCE V, PROMUS]
|
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
HSMN NewsFeed,
13 May 2008:
Devices, Interventional Cardiology
[Abbott, SPIRIT III trial, XIENCE V, drug eluting stent, TAXUS]
|
Medtronic Announces Start of International Study Comparing Endeavor(R) Resolute Drug-Eluting Stent to Abbott's Xience(R) V
HSMN NewsFeed,
12 May 2008:
Devices, Interventional Cardiology
[Medtronic, Endeavor Resolute, Abbott, Xience V, drug eluting stent]
|
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
HSMN NewsFeed,
8 May 2008:
Biopharmaceuticals
[Abbott, hydrocodone, acetaminophen, Vicodin CR]
|
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel
[Rib-X Pharmaceuticals]
|
Abbott, Takeda Conclude TAP Joint Venture
HSMN NewsFeed,
1 May 2008:
Biopharmaceuticals
[Abbott, Takeda Pharmaceutical, TAP Pharmaceutical Products]
|
Mylan Announces Final FDA Approval for Trandolapril Tablets
HSMN NewsFeed,
29 Apr 2008:
Biopharmaceuticals, Generics, FDA
[Mylan, Trandolapril, Abbott, Mavik]
|
HeartWare Appoints David R. Hathaway, M.D. Chief Medical Officer
HSMN NewsFeed,
28 Apr 2008:
Devices, Personnel
[HeartWare]
|
Facet Solutions, Inc. Expands Executive Management Team
HSMN NewsFeed,
25 Apr 2008:
Devices, Neurosurgery, Orthopaedic, Personnel
[Facet Solutions]
|
Hana Biosciences Appoints Anne E. Hagey, M.D., Vice President and Chief Medical Officer
HSMN NewsFeed,
24 Apr 2008:
Biopharmaceuticals, Personnel
[Hana Biosciences]
|
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
HSMN NewsFeed,
22 Apr 2008:
Devices, Interventional Cardiology
[Abbott, SPIRIT III, XIENCE V, TAXUS, drug eluting stent]
|
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
HSMN NewsFeed,
22 Apr 2008:
Devices, Endocrinology, Distribution
[Abbott, Smiths Medical MD, FreeStyle Navigator, Continuous Glucose Monitoring]
|
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
HSMN NewsFeed,
16 Apr 2008:
Biopharmaceuticals, Regulatory
[Abbott, Eisai, HUMIRA, adalimumab, rheumatoid arthritis]
|
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
HSMN NewsFeed,
14 Apr 2008:
Devices, Endocrinology
[Abbott, FreeStyle Freedom, diabetes]
|
Celera Grants License to Merck & Co., Inc. for Cancer Targets
HSMN NewsFeed,
10 Apr 2008:
Biopharmaceuticals, Oncology, Licensing
[ Celera, Applera, Merck]
|
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
HSMN NewsFeed,
7 Apr 2008:
Biopharmaceuticals, Regulatory, HIV/AIDS
[Abbott, Kaletra, lopinavir, ritonavir, protease inhibitor]
|
Ipsen: Appointment of Dominique Bridon, PhD as Vice President, Discovery
HSMN NewsFeed,
1 Apr 2008:
Biopharmaceuticals, Personnel
[Ipsen]
|
Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Cardiology
[Abbott, ABT-335, TriLipix, fenofibric acid]
|
Patients Treated with Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM)) Reported Significantly Less Flushing Than Patients Treated with Niaspan(TM) in Phase III Study
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Cardiology
[Merck, CORDAPTIVE, niacin, laropiprant]
|
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
HSMN NewsFeed,
31 Mar 2008:
Devices, Interventional Cardiology
[Boston Scientific, SPIRIT II, XIENCE V, PROMUS, Abbott, drug eluting stent]
|
SPIRIT II Explores Long-Term Performance of XIENCE V Stent
HSMN NewsFeed,
31 Mar 2008:
Devices, Interventional Cardiology
[SCAI-ACCi2, XIENCE V, Taxus, SPIRIT II, Abbott, Boston Scientific]
|
Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
HSMN NewsFeed,
31 Mar 2008:
Devices, Interventional Cardiology
[Abbott, SPIRIT II, XIENCE V, drug eluting stent]
|
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
HSMN NewsFeed,
26 Mar 2008:
Biopharmaceuticals, Gastroenterology
[Shire plc, TAP Pharmaceutical, LIALDA , mesalamine, ulcerative colitis]
|
Pharming signs distribution agreement for Rhucin(R) in Turkey
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals, Distribution
[Pharming Group, Eczacibasi Group, Rhucin, Hereditary Angioedema]
|
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
HSMN NewsFeed,
19 Mar 2008:
Biopharmaceuticals
[Abbott, Takeda Pharmaceutical, TAP Pharmaceutical Products]
|
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
HSMN NewsFeed,
13 Mar 2008:
Devices, FDA, Endocrinology
[Abbott, FreeStyle Navigator, Continuous Glucose Monitoring, diabetes]
|
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
HSMN NewsFeed,
12 Mar 2008:
Biopharmaceuticals, Personnel
[Endo Pharmaceuticals]
|
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
HSMN NewsFeed,
11 Mar 2008:
Devices, Interventional Cardiology, Regulatory
[Abbott, XIENCE V, Everolimus, drug eluting stent]
|
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
HSMN NewsFeed,
7 Mar 2008:
Diagnostics, Biopharmaceuticals, Oncology
[Abbott, Genentech, Roche Group, OSI Pharmaceuticals, Tarceva, erlotinib]
|
Luminex Announces Executive Management Changes
HSMN NewsFeed,
4 Mar 2008:
Diagnostics, Personnel
[Luminex]
|
Luminex and Abbott Sign Agreement for Global Distribution of the xTAG(TM) Respiratory Viral Panel
HSMN NewsFeed,
28 Feb 2008:
Diagnostics, Distribution
[Luminex Molecular Diagnostics, Abbott, xTAG, Respiratory Viral Panel]
|
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, Personnel
[OVATION Pharmaceuticals]
|
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, Personnel
[Ocera Therapeutics]
|
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
HSMN NewsFeed,
22 Feb 2008:
Biopharmaceuticals, FDA
[Abbott, HUMIRA, adalimumab, juvenile idiopathic arthritis]
|
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
HSMN NewsFeed,
15 Feb 2008:
Biopharmaceuticals, Cardiology, FDA
[Abbott, SIMCOR, Niaspan, niacin, simvastatin]
|
Carl Hull Named President and Chief Operating Officer of Gen-Probe
HSMN NewsFeed,
11 Feb 2008:
Diagnostics, Personnel
[Gen-Probe]
|
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
HSMN NewsFeed,
11 Feb 2008:
Devices, Interventional Cardiology
[Boston Scientific, PROENCY, PROMUS, Olimus-eluting stent, drug eluting stent]
|
Mylan Restores Availability of Generic Levothyroxine in Florida
HSMN NewsFeed,
8 Feb 2008:
Biopharmaceuticals, Generics
[Mylan, Levothyroxine, Synthroid, Abbott]
|
MedImmune Submits Biologics License Application to FDA for Motavizumab
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals
[MedImmune, motavizumab, respiratory syncytial virus]
|
Abbott Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France
HSMN NewsFeed,
1 Feb 2008:
Devices, Reimbursement, Interventional Cardiology
[Abbott, XIENCE V, drug eluting stent, Everolimus]
|
Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
HSMN NewsFeed,
31 Jan 2008:
Biopharmaceuticals, Diagnostics, Acquisitions
[Isis Pharmaceuticals, Abbott, Ibis Biosciences, T5000 Biosensor]
|
NMT Medical Announces Separation of Chairman and Chief Executive Officer Roles
HSMN NewsFeed,
30 Jan 2008:
Devices, Interventional Cardiology, Personnel
[NMT Medical]
|
Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
HSMN NewsFeed,
28 Jan 2008:
Biopharmaceuticals, HIV/AIDS, Regulatory
[Abbott, Kaletra, Aluvia, lopinavir/ritonavir, protease inhibitor]
|
Back pain treatment milestone: Bon Secours DePaul Medical Center orthopedic surgeon is first in Virginia to implant 'motion preserving' spinal device to treat Lumbar Spinal Stenosis
HSMN NewsFeed,
23 Jan 2008:
Devices, Orthopaedic
[Applied Spine Technologies, Stabilimax NZ, Lumbar Spinal Stenosis]
|
AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
HSMN NewsFeed,
21 Jan 2008:
Biopharmaceuticals, HIV/AIDS
[AIDS Healthcare Foundation, Tibotec Pharmaceuticals, etravirine]
|
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
HSMN NewsFeed,
20 Jan 2008:
Devices, Personnel
[Sorenson Companies, Sorenson Medical, Deseret, Abbott, Hospira]
|
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
HSMN NewsFeed,
18 Jan 2008:
Biopharmaceuticals, FDA
[Abbott, HUMIRA, adalimumab, psoriasis]
|
Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
HSMN NewsFeed,
18 Jan 2008:
Diagnostics, FDA
[Abbott, HTLV-I, HTLV-II, T-cell leukemia]
|
Naviscan PET Systems Announces New Commercial and Technology Leadership Team
HSMN NewsFeed,
7 Jan 2008:
Devices, Radiology, Personnel
[Naviscan PET Systems]
|
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
HSMN NewsFeed,
4 Jan 2008:
Devices, Dermatology, Venture Capital
[Follica, androgenetic alopecia, alopecia]
|
Watson Launches Generic Biaxin(R) XL
HSMN NewsFeed,
3 Jan 2008:
Biopharmaceuticals, Generics
[Watson Pharmaceuticals, Clarithromycin, Abbott, Biaxin]
|
Coronado Builds Core Management Team
HSMN NewsFeed,
3 Jan 2008:
Biopharmaceuticals, Oncology, Personnel
[Coronado Biosciences]
|
CytoCore Names President, International Operations
HSMN NewsFeed,
28 Dec 2007:
Diagnostics, Personnel
[CytoCore]
|
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed,
26 Dec 2007:
Biopharmaceuticals, FDA
[Noven Pharmaceuticals, Stavzor, valproic acid]
|
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals, Regulatory
[Abbott, HUMIRA, adalimumab, psoriasis]
|
Immusol Changes Name to ItherX, Names Jeffrey F. McKelvy President and Chief Executive Officer
HSMN NewsFeed,
17 Dec 2007:
Biopharmaceuticals, Personnel
[ItherX Pharmaceuticals, Immusol]
|
VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
HSMN NewsFeed,
12 Dec 2007:
Devices, Monitoring, Personnel
[VivoMetrics]
|
Sutura Settles Patent Infringement Lawsuit With Abbott Laboratories
HSMN NewsFeed,
4 Dec 2007:
Devices, Interventional, Litigation, Licensing
[Sutura, Abbott, vascular closure]
|
MedicalCV, Inc. Announces SOLAR(TM) System Cases in Milwaukee
HSMN NewsFeed,
4 Dec 2007:
Devices, Cardiology
[MedicalCV, Surgical Ablation, cardiac ablation]
|
Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
HSMN NewsFeed,
29 Nov 2007:
Devices, Interventional Cardiology
[Boston Scientific, PROMUS , XIENCE V, Abbott, drug eluting stent]
|
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
HSMN NewsFeed,
29 Nov 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE V, drug eluting stent]
|
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29
HSMN NewsFeed,
27 Nov 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE V, drug eluting stent]
|
Evalve(R) Completes $60 Million Series D Financing
HSMN NewsFeed,
27 Nov 2007:
Devices, Cardiology, Venture Capital
[ Evalve, EVEREST study, MitraClip]
|
St. Jude Medical Announces FDA Approval of Epic Stented Tissue Valve with Anti-Calcification Technology
HSMN NewsFeed,
26 Nov 2007:
Devices, Cardiology, FDA
[St. Jude Medical, Epic Stented Tissue Valve, Epic Valve]
|
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
16 Nov 2007:
Biopharmaceuticals, Regulatory
[Abbott, HUMIRA, adalimumab, psoriasis]
|
Significant Changes in Store for Growing HIV Market
HSMN NewsFeed,
15 Nov 2007:
Biopharmaceuticals, HIV/AIDS
[GlaxoSmithKline, Gilead, Bristol-Myers Squibb, Tibotec, Johnson & Johnson]
|
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
HSMN NewsFeed,
13 Nov 2007:
Biopharmaceuticals, Personnel
[Halozyme Therapeutics]
|
Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
HSMN NewsFeed,
12 Nov 2007:
Biopharmaceuticals, HIV/AIDS, FDA
[Abbott, Kaletra, Aluvia, lopinavir, ritonavir]
|
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab, uveitis, ankylosing spondylitis]
|
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
HSMN NewsFeed,
5 Nov 2007:
Devices, Interventional Cardiology, FDA
[Abbott, XIENCE, Everolimus, drug eluting stent]
|
FzioMed Appoints Todd Fanning as Vice President of Sales
HSMN NewsFeed,
5 Nov 2007:
Devices, Personnel
[FzioMed, Oxiplex, Laresse]
|
Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
HSMN NewsFeed,
4 Nov 2007:
Biopharmaceuticals, Cardiology
[Abbott, SIMCOR, Niaspan, niacin, simvastatin]
|
Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
HSMN NewsFeed,
1 Nov 2007:
Devices, Personnel
[WaveSense]
|
Gene Logic Selects New Company Name: Ore Pharmaceuticals Inc.
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals
[Gene Logic, Ore Pharmaceuticals, Ocimum Biosolutions]
|
MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs
HSMN NewsFeed,
24 Oct 2007:
Devices, Personnel
[MicroCHIPS Inc]
|
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Neurology, FDA
[Noven Pharmaceuticals, Stavzor, valproic acid]
|
Celera Completes Acquisition of Atria Genetics, Inc.
HSMN NewsFeed,
23 Oct 2007:
Diagnostics, Acquisitions
[ Celera, Atria Genetics, Applera]
|
Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
HSMN NewsFeed,
23 Oct 2007:
Devices, Interventional
[Abbott, ACCULINK, Xact, carotid stent, embolic protection]
|
VertiFlex Appoints Brad Hancock Vice President of Sales
HSMN NewsFeed,
23 Oct 2007:
Devices, Neurosurgery, Orthopaedic
[VertiFlex]
|
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
HSMN NewsFeed,
22 Oct 2007:
Devices, Interventional Cardiology
[Abbott, bioabsorbable drug eluting stent, ABSORB trial]
|
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
HSMN NewsFeed,
22 Oct 2007:
Devices, Interventional Cardiology
[Boston Scientific, PROMUS, TAXUS, drug eluting stent]
|
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
HSMN NewsFeed,
22 Oct 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE, Everolimus, drug eluting stent, coronary stent]
|
CeNeRx BioPharma Adds Dr. Daniel Burch as Chief Medical Officer
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Personnel
[CeNeRx BioPharma]
|
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, Pain Mangement, FDA
[Neuromed Pharmaceuticals, NMED-1077, OROS , Hydromorphone]
|
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
HSMN NewsFeed,
15 Oct 2007:
Diagnostics, Cardiology
[ Celera , ARIC study, KIF6, MYH15, PALLD, SNX19, VAMP8]
|
Celera Completes Acquisition of Berkeley HeartLab, Inc.
HSMN NewsFeed,
15 Oct 2007:
Diagnostics, Mergers & Acquisitions, Cardiology
[ Celera, Berkeley HeartLab]
|
Dr. Michael Jolley Joins Cytocore as Director of Assay Development
HSMN NewsFeed,
3 Oct 2007:
Diagnostics, Personnel
[CytoCore]
|
Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
HSMN NewsFeed,
2 Oct 2007:
Diagnostics, FDA
[Abbott, i-STAT , i-STAT CHEM8]
|
VeraLight Names Mirasol Panlilio VP Marketing and Sales
HSMN NewsFeed,
27 Sep 2007:
Devices, Endocrinology, Personnel
[VeraLight, Scout DS, diabetes]
|
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
HSMN NewsFeed,
27 Sep 2007:
Biopharmaceuticals, Personnel
[Asphelia Pharmaceuticals]
|
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
HSMN NewsFeed,
25 Sep 2007:
Devices, Interventional
[Abbott, Herculink, Cobalt Chromium, Renal Stent, renal artery stenosis]
|
Celera to Acquire Atria Genetics
HSMN NewsFeed,
20 Sep 2007:
Diagnostics, Acquisitions
[ Celera, Atria Genetics, Applera]
|
BiPar Names G. Kirk Raab Acting Chief Executive Officer
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals, Oncology, Personnel
[BiPar Sciences]
|
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Personnel
[Anika Therapeutics]
|
New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, HIV/AIDS
[Tibotec Therapeutics, PREZISTA, darunavir, ritonavir, TRUVADA, ARTEMIS]
|
Former FDA Official John Taylor III to Join BIO as Executive Vice President of Health
HSMN NewsFeed,
17 Sep 2007:
Biopharmaceuticals, Personnel
[Biotechnology Industry Organization]
|
EraGen Announces Appointment of Blanc as Vice President, Corporate Development
HSMN NewsFeed,
17 Sep 2007:
Diagnostics, Personnel
[EraGen BioSciences]
|
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed,
12 Sep 2007:
Biopharmaceuticals, Personnel
[Micromet]
|
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed,
10 Sep 2007:
Biopharmaceuticals, Oncology, Litigation, Licensing
[ImClone Systems, Repligen, ERBITUX, Cetuximab]
|
Athersys Elects Jeff Randall to Board of Directors
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Personnel
[Athersys]
|
REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
HSMN NewsFeed,
5 Sep 2007:
Cardiology
[REACH Registry, atherothrombosis, peripheral arterial disease]
|
Jerini Regains Commercialization Rights to Icatibant for the Treatment of Hereditary Angioedema in North America
HSMN NewsFeed,
4 Sep 2007:
Biopharmaceuticals
[Jerini, Kos Life Sciences, Icatibant, Abbott, Hereditary Angioedema]
|
Celera to Acquire Berkeley HeartLab, Inc.
HSMN NewsFeed,
4 Sep 2007:
Diagnostics, Mergers & Acquisitions
[Celera Group, Applera, Berkeley HeartLab]
|
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
HSMN NewsFeed,
31 Aug 2007:
Biopharmaceuticals
[Abbott, AstraZeneca, ABT-335, fenofibrate, CRESTOR, rosuvastatin]
|
Entelos Acquires Iconix Biosciences, Inc.
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals, Mergers & Acquisitions
[Entelos, Iconix Biosciences]
|
Ventaira Pharmaceuticals Appoints Lex Adjei, Ph.D. as Vice President, Research and Development
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel
[Ventaira Pharmaceuticals]
|
Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel
[Oscient Pharmaceuticals]
|
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
HSMN NewsFeed,
21 Aug 2007:
Biopharmaceuticals, Venture Capital
[Neuromed Pharmaceuticals]
|
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
HSMN NewsFeed,
20 Aug 2007:
Biopharmaceuticals, Generics, FDA
[Ranbaxy Pharmaceuticals, Hydrocodone Bitartrate, Acetaminophen]
|
MINRAD International, Inc. Announces Appointment of Dennis Goupil, PhD, as Senior Vice President Technical and Terence Vollrath as Vice President Operations
HSMN NewsFeed,
17 Aug 2007:
Devices, Personnel
[MINRAD International]
|
Alpine Biomed Names John Arnott Chief Executive Officer
HSMN NewsFeed,
14 Aug 2007:
Devices, Personnel
[Alpine Biomed]
|
Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical & Regulatory Affairs
HSMN NewsFeed,
13 Aug 2007:
Biopharmaceuticals, Personnel
[Cytochroma]
|
Abbott Vascular Launches Crossroads Institute in Japan
HSMN NewsFeed,
9 Aug 2007:
Devices, Interventional
[Abbott, Abbott Vascular, Crossroads Institute]
|
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
HSMN NewsFeed,
9 Aug 2007:
Diagnostics, HIV/AIDS, FDA
[Abbott, RealTime HIV-1, viral load test]
|
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
HSMN NewsFeed,
7 Aug 2007:
Biopharmaceuticals, Personnel
[NeurAxon]
|
Abbott Chief Operating Officer Richard A. Gonzalez to Retire
HSMN NewsFeed,
3 Aug 2007:
Biopharmaceuticals, Devices, Personnel
[Abbott]
|
Neuromed Appoints Mario Orlando as Vice President of Marketing
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
Pathway Medical Adds Medical Device Veteran Paul Buckman to Board of Directors, Appoints Vice President of Manufacturing
HSMN NewsFeed,
31 Jul 2007:
Devices, Interventional, Personnel
[Pathway Medical]
|
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
HSMN NewsFeed,
31 Jul 2007:
Biopharmaceuticals, Personnel
[Gene Logic]
|
OrbusNeich Expands Global Sales and Marketing Team
HSMN NewsFeed,
30 Jul 2007:
Devices, Interventional Cardiology, Personnel
[OrbusNeich, Massimo Chiesa, Per Arne Winberg]
|
Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS
HSMN NewsFeed,
20 Jul 2007:
Biopharmaceuticals, Regulatory, HIV/AIDS
[Abbott, Kaletra, Aluvia, lopinavir, ritonavir]
|
Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women
HSMN NewsFeed,
19 Jul 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE V, SPIRIT WOMEN Trial, drug eluting stent]
|
Abbott Announces Approval of First Fully-Automated Blood Screening Test for Hepatitis C Antibodies
HSMN NewsFeed,
12 Jul 2007:
Diagnostics, FDA
[Abbott, Hepatitis C , HCV, HCV test]
|
Abbott Announces Termination of Contract With GE
HSMN NewsFeed,
11 Jul 2007:
Diagnostics, Mergers & Acquisitions
[Abbott, GE , GE Healthcare]
|
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed,
10 Jul 2007:
Biopharmaceuticals, Mergers & Acquisitions
[Noven Pharmaceuticals, JDS Pharmaceuticals]
|
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
HSMN NewsFeed,
6 Jul 2007:
Biopharmaceuticals, HIV/AIDS
[Tibotec Therapeutics, PREZISTA, darunavir, TITAN study, antiretroviral]
|
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
HSMN NewsFeed,
5 Jul 2007:
Biopharmaceuticals, HIV/AIDS
[Tibotec Therapeutics, PREZISTA, darunavir]
|
New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
HSMN NewsFeed,
29 Jun 2007:
Biopharmaceuticals
[Abbott, MedImmune, Synagis, palivizumab]
|
Presidio Pharmaceuticals Announces Key Executive Management Additions
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Personnel
[Presidio Pharmaceuticals]
|
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
HSMN NewsFeed,
21 Jun 2007:
Biopharmaceuticals, Personnel
[Elusys Therapeutics]
|
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
HSMN NewsFeed,
21 Jun 2007:
Diagnostics, Regulatory
[Abbott, Celera , hepatitis B, RealTime HBV test, m2000]
|
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Generics, Litigation
[IMPAX Laboratories, Abbott, Depakote, Depakote ER]
|
Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
HSMN NewsFeed,
15 Jun 2007:
Biopharmaceuticals
[Abbott, rheumatoid arthritis, HUMIRA, adalimumab]
|
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
HSMN NewsFeed,
7 Jun 2007:
Biopharmaceuticals, Gastroenterology, Regulatory
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Two Significant Hires Round-Out VaxInnate's Core Management Team
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Personnel
[VaxInnate, vaccine]
|
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Oncology
[Abbott, Caprion Proteomics, Thallion Pharmaceuticals, CellCarta]
|
Abbott Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System
HSMN NewsFeed,
6 Jun 2007:
Devices, Monitoring, Endocrinology, Regulatory
[Abbott, FreeStyle Navigator, Glucose Monitor, diabetes]
|
Vanda Pharmaceuticals Announces Board Changes
HSMN NewsFeed,
5 Jun 2007:
Biopharmaceuticals, Neurology, Personnel
[Vanda Pharmaceuticals]
|
Abbott Signs Agreement With Novation for Diagnostic Equipment and Tests
HSMN NewsFeed,
4 Jun 2007:
Diagnostics, Group Purchasing
[Abbott, Novation]
|
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
HSMN NewsFeed,
1 Jun 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE V, drug eluting stent, Everolimus]
|
MedPointe Pharmaceuticals Announces the Appointment of John J. Howarth to Vice President of Public Affairs and Investor Relations
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Personnel
[MedPointe Pharmaceuticals]
|
IDM Pharma Names Timothy P. Walbert as President and CEO
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Personnel
[IDM Pharma]
|
Abbott Diagnostics Issues Voluntary Nationwide Recall of ARCHITECT(R) STAT Troponin-I Test
HSMN NewsFeed,
25 May 2007:
Diagnostics, Cardiology, Product Recall
[Abbott, ARCHITECT STAT, Troponin-I]
|
Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease
HSMN NewsFeed,
23 May 2007:
Devices, Interventional
[Abbott, everolimus, drug eluting stent, peripheral arterial disease]
|
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
HSMN NewsFeed,
23 May 2007:
Biopharmaceuticals, Urology
[Spectrum Pharmaceuticals, ozarelix, benign prostatic hypertrophy]
|
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems
HSMN NewsFeed,
22 May 2007:
Devices, Interventional Cardiology
[Boston Scientific, SPIRIT FIRST, TAXUS Express2, XIENCE V, PROMUS stent]
|
Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
HSMN NewsFeed,
22 May 2007:
Devices, Interventional Cardiology
[Abbott, ABSORB trial, bioabsorbable drug eluting stent]
|
Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials
HSMN NewsFeed,
22 May 2007:
Devices, Interventional Cardiology
[Abbott, SPIRIT FIRST trial, XIENCE V, MULTI-LINK VISION, drug eluting stent]
|
CytRx Names Shi Chung Ng, Ph.D., Senior Vice President of Research and Development
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Personnel
[CytRx]
|
New Analysis of Data Shows Treatment With Abbott's HUMIRA(R) (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Gastroenterology
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
HSMN NewsFeed,
21 May 2007:
Devices, Drug Delivery, Personnel
[Milestone Scientific]
|
Medicis Begins Shipping PERLANE to Physicians
HSMN NewsFeed,
21 May 2007:
Biopharmaceuticals, Dermatology
[Medicis Pharmaceutical, PERLANE , RESTYLANE, hyaluronic acid, dermal filler]
|
Medarex Announces the Appointment of Mr. Howard H. Pien as President and Chief Executive Officer and Member of the Medarex Board of Directors
HSMN NewsFeed,
16 May 2007:
Biopharmaceuticals, Personnel
[Medarex]
|
Boston Scientific Announces Schedule for EuroPcr 2007
HSMN NewsFeed,
15 May 2007:
Devices, Interventional Cardiology
[Boston Scientific]
|
Sepracor Announces Management Transition
HSMN NewsFeed,
15 May 2007:
Biopharmaceuticals, Personnel
[Sepracor, Adrian Adams]
|
Gene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug Candidates
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals, Licensing
[Gene Logic, Abbott]
|
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals, Generics, FDA
[Teva Pharmaceutical, Omnicef, Cefdinir, Abbott]
|
Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension, 250 mg/5 mL, Launches Entire Product Family
HSMN NewsFeed,
8 May 2007:
Biopharmaceuticals, Generics, FDA
[Lupin Pharmaceuticals, Cefdinir, Omnicef, Abbott, antibiotic]
|
CytoCore Taps Dr. Richard Domanik as New President
HSMN NewsFeed,
7 May 2007:
Diagnostics, Personnel
[CytoCore]
|
Abbott Seeks U.S. and E.U. Regulatory Approvals for HUMIRA(R) (Adalimumab) as a Treatment for Juvenile Rheumatoid Arthritis
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals, FDA, Regulatory
[Abbott, HUMIRA, adalimumab, juvenile rheumatoid arthritis, rheumatoid arthritis]
|
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals
[Royalty Pharma, Remicade]
|
Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals, Dermatology
[Abbott, ABT-874, psoriasis, monoclonal antibody]
|
Enzo Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott
HSMN NewsFeed,
3 May 2007:
Diagnostics, Licensing
[Enzo Biochem, Abbott, fluorescence in situ hybridization]
|
diaDexus Appoints Charles Patrick to Board of Directors
HSMN NewsFeed,
3 May 2007:
Diagnostics, Personnel
[diaDexus]
|
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Personnel, Venture Capital
[Solace Pharmaceuticals]
|
ReVision Optics, Inc. Raises $25M in Series D Financing
HSMN NewsFeed,
30 Apr 2007:
Devices, Ophthalmology, Venture Capital
[ReVision Optics]
|
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Gastroenterology, Regulatory
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Northstar Neuroscience Announces Management and Board Succession Plan
HSMN NewsFeed,
26 Apr 2007:
Devices, Neurology, Personnel
[Northstar Neuroscience]
|
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
HSMN NewsFeed,
25 Apr 2007:
Diagnostics, Oncology, Licensing
[ Celera , Laboratory Corporation of America, LabCorp, breast cancer]
|
Medtronic Responds to ''Inequitable Conduct'' Decision by U.S. District Court in Stent Litigation
HSMN NewsFeed,
24 Apr 2007:
Devices, Litigation, Interventional Cardiology
[Medtronic, Lau patent, stent patent, Guidant, Abbott]
|
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Drug Delivery, Licensing
[Neuromed Technologies, ALZA Corp, OROS , Hydromorphone]
|
Abbott Submits New Drug Application for Combination Niaspan(R)/Simvastatin Tablet
HSMN NewsFeed,
20 Apr 2007:
Biopharmaceuticals, Oncology, FDA
[Abbott, Niaspan, Simvastatin]
|
Abbott and Premier Sign Contract for Diagnostic Tests
HSMN NewsFeed,
16 Apr 2007:
Diagnostics, Group Purchasing
[Abbott, Premier Purchasing, immunochemistry, CELL-DYN]
|
Abbott Announces FDA Clearance and Launch of New FreeStyle Lite(TM) Blood Glucose Monitoring System
HSMN NewsFeed,
16 Apr 2007:
Devices, Monitoring, Endocrinology, FDA
[Abbott, FreeStyle Lite, Blood Glucose Monitor]
|
Cardica Appoints Ric Ruedy Vice President of Regulatory, Clinical and Quality Affairs
HSMN NewsFeed,
16 Apr 2007:
Devices, Cardiology, Personnel
[Cardica]
|
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
HSMN NewsFeed,
16 Apr 2007:
Devices, Interventional Cardiology
[Volcano, Intravascular Ultrasound, Fractional Flow Reserve]
|
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Personnel
[Ipsen]
|
Dr. James Tanguay Joins Vion Pharmaceuticals' Senior Management Team
HSMN NewsFeed,
11 Apr 2007:
Biopharmaceuticals, Personnel
[Vion Pharmaceuticals]
|
Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab]
|
Phase Bioscience Strengthens Management Team
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Personnel
[Phase Bioscience]
|
Abbott Agrees With World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir)
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, HIV/AIDS
[Abbott, Kaletra, Aluvia, lopinavir, ritonavir]
|
Abbott Announces FDA Approval of a New Coated Niaspan Tablet
HSMN NewsFeed,
6 Apr 2007:
Biopharmaceuticals, FDA
[Abbott, Niaspan, niacin]
|
Intranasal Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran, Peter F. Young, as President and Chief Executive Officer
HSMN NewsFeed,
5 Apr 2007:
Biopharmaceuticals, Drug Delivery, Personnel
[Intranasal Therapeutics]
|
Akorn, Inc. Names Shawn L. Silvestri, Ph.D. As Vice President, New Product Development
HSMN NewsFeed,
5 Apr 2007:
Biopharmaceuticals, Personnel
[Akorn]
|
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
HSMN NewsFeed,
4 Apr 2007:
Biopharmaceuticals, Drug Delivery, Oncology
[DOR BioPharma, Lipid Polymer Micelle, leuprolide, prostate cancer]
|
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Dermatology, FDA
[Abbott, HUMIRA, adalimumab, psoriasis]
|
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
HSMN NewsFeed,
26 Mar 2007:
Devices, Interventional
[Abbott, ACCULINK, carotid stent, Emboshield, Embolic Protection]
|
Spirit III Clinical Trial Demonstrates Positive Performance for Both TAXUS(R) and PROMUS(TM) Drug-Eluting Stent Systems
HSMN NewsFeed,
24 Mar 2007:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS Express, Paclitaxel, drug eluting stent]
|
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT III U.S. Pivotal Clinical Trial
HSMN NewsFeed,
24 Mar 2007:
Devices, Interventional Cardiology
[Abbott, XIENCE, Everolimus, drug eluting stent]
|
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
HSMN NewsFeed,
24 Mar 2007:
Devices, Interventional Cardiology
[Abbott, Bioabsorbable Stent, drug eluting stent]
|
Boston Scientific Announces Schedule for ACC 2007
HSMN NewsFeed,
20 Mar 2007:
Devices, Interventional Cardiology
[Boston Scientific]
|
Spectrum Pharmaceuticals Bolsters Ozarelix Team with Addition of In-House Urology Expert Bela S. Denes, MD, FACS
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Urology, Personnel
[Spectrum Pharmaceuticals]
|
AVANIR Pharmaceuticals Appoints New Chief Executive Officer
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Personnel
[ AVANIR Pharmaceuticals]
|
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Generics, FDA
[Mylan Laboratories, Divalproex, Abbott Laboratories, Depakote]
|
Calistoga Pharmaceuticals, A Newly Formed Drug Development Company, Announces Its Formation and Completion of a $21 Million Series A Financing
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Venture Capital
[Calistoga Pharmaceuticals]
|
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
HSMN NewsFeed,
2 Mar 2007:
Biopharmacetuicals
[Oscient Pharmaceuticals, Abbott Canada, Abbott, gemifloxacin, FACTIVE]
|
Medtronic Announces Succession Plans for CEO and COO
HSMN NewsFeed,
28 Feb 2007:
Devices, Personnel
[Medtronic, William A. Hawkins, Arthur D. Collins]
|
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
HSMN NewsFeed,
28 Feb 2007:
Biopharmaceuticals, Personnel
[Tercica]
|
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
HSMN NewsFeed,
27 Feb 2007:
Biopharmaceuticals, Gastroenterology, FDA
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Takeda and TAP to Promote Sucampo's AMITIZA(R) in the United States
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Gastroenterology
[Takeda Pharmaceuticals, TAP Pharmaceutical, Sucampo, AMITIZA, lubiprostone]
|
Jeffrey R. Binder - Seasoned Orthopedic Medical Device Leader - Named President and Chief Executive Officer of Biomet, Inc.
HSMN NewsFeed,
26 Feb 2007:
Devices, Orthopaedic, Personnel
[Biomet , Jeffrey R. Binder]
|
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
HSMN NewsFeed,
22 Feb 2007:
Diagnostics, Oncology
[Celera , Applera, prognostic constellation, breast cancer]
|
PDL BioPharma Announces New Chief Medical Officer and Appoints Chief Scientific Officer to Its Board of Directors
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel
[PDL BioPharma]
|
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel
[VIRxSYS, VRX496, lentiviral vector]
|
Inotek Pharmaceuticals Announces Additions to its Board of Directors
HSMN NewsFeed,
14 Feb 2007:
Biopharmaceuticals, Personnel
[Inotek Pharmaceuticals]
|
Carl Hull to Join Gen-Probe as Executive Vice President and Chief Operating Officer
HSMN NewsFeed,
13 Feb 2007:
Diagnostics, Personnel
[Gen-Probe]
|
HemoSense Names Conan Li to VP of Research & Development
HSMN NewsFeed,
9 Feb 2007:
Diagnostics, Personnel
[HemoSense]
|
Abbott Statement Regarding CMS' Proposed Expansion of Coverage for Carotid Artery Stenting
HSMN NewsFeed,
6 Feb 2007:
Devices, Interventional, Reimbursement
[Abbott, Abbott Vascular, carotid stent]
|
Abbott to Initiate First Study to Evaluate XIENCE(TM) V Everolimus Eluting Coronary Stent System in Treatment of Women With Cardiovascular Disease
HSMN NewsFeed,
6 Feb 2007:
Devices, Interventional Cardiology
[Abbott, SPIRIT WOMEN trial, XIENCE V, drug eluting stent]
|
Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's HUMIRA(R) in New Phase III Study
HSMN NewsFeed,
2 Feb 2007:
Biopharmaceuticals, Dermatology
[Abbott, HUMIRA, adalimumab, Psoriasis]
|
Schering-Plough Appoints Shaju Backer
HSMN NewsFeed,
31 Jan 2007:
Biopharmaceuticals, Personnel
[Schering-Plough]
|
Home Diagnostics Appoints Vice President of Marketing
HSMN NewsFeed,
30 Jan 2007:
Diagnostics, Personnel
[Home Diagnostics]
|
Verax Biomedical Appoints James Koziarz, Ph.D. to Board of Directors
HSMN NewsFeed,
25 Jan 2007:
Diagnostics, Personnel
[Verax Biomedical]
|
FDA Clears BioView Duet(TM) System for Automated FISH Scanning of Breast Cancer Tissue Specimens
HSMN NewsFeed,
25 Jan 2007:
Diagnostics, Oncology, FDA
[BioView, BioView Duet, fluorescence in situ hybridization]
|
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
HSMN NewsFeed,
25 Jan 2007:
Biopharmaceuticals, Urology
[Spectrum Pharmaceuticals, ozarelix, benign prostate hypertrophy]
|
Scientists Discover New Gene Associated with Crohn's Disease
HSMN NewsFeed,
24 Jan 2007:
Biopharmaceuticals, Gastroenterology
[Applied Biosystems, Applera Corporation, Crohn's disease]
|
Theragenics(R) Announces Appointment of Chief Medical Director
HSMN NewsFeed,
23 Jan 2007:
Devices, Personnel
[Theragenics]
|
Abbott To Sell Its Core Laboratory Diagnostics Business, Including Point Of Care, To GE For $8.13 Billion
HSMN NewsFeed,
18 Jan 2007:
Diagnostics, Mergers & Acquisitions
[Abbott, GE , Abbott Diagnostics, Abbott Point of Care]
|
Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe
HSMN NewsFeed,
11 Jan 2007:
Devices, Interventional Cardiology
[Abbott, Boston Scientific, PROMUS, Everolimus, drug eluting stent, XIENCE]
|
Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System
HSMN NewsFeed,
11 Jan 2007:
Devices, Interventional Cardiology
[Boston Scientific, PROMUS, Everolimus, drug eluting stent, XIENCE, Abbott]
|
Maureen Mende Joins Diamics as Director of Regulatory Affairs and Quality Assurance
HSMN NewsFeed,
8 Jan 2007:
Devices, Diagnostics, Personnel
[Diamics]
|
Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
HSMN NewsFeed,
8 Jan 2007:
Diagnostics, Regulatory
[Abbott, Celera, Abbott m2000]
|
French Court Rules in Favor of evYsio Medical Devices in Patent Litigation Against Abbott Laboratories
HSMN NewsFeed,
4 Jan 2007:
Devices, Interventional Cardiology, Litigation
[evYsio Medical Devices, Abbott, Xience V, drug eluting stent]
|
Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals, Diagnostics, Litigation
[Innogenetics, Abbott]
|
Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Urology
[Spectrum Pharmaceuticals, ozarelix, Benign Prostate Hypertrophy]
|
Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
HSMN NewsFeed,
29 Dec 2006:
Biopharmaceuticals, Licensing
[Oscient Pharmaceuticals, LG Life Sciences, FACTIVE, gemifloxacin]
|
Healthcare Marketing Expert Joins Valeritas as Vice President of Marketing & Marketing Operations
HSMN NewsFeed,
22 Dec 2006:
Devices, Drug Delivery, Personnel
[Valeritas, BioValve, h-Patch]
|
Sutura Files Patent Infringement Lawsuit Against Abbott Laboratories and Perclose
HSMN NewsFeed,
21 Dec 2006:
Devices, Interventional, Litigation
[Sutura, Abbott, Perclose, SuperStitch]
|
Celsion Corporation Announces New President/CEO
HSMN NewsFeed,
21 Dec 2006:
Devices, Urology, Personnel
[Celsion Corporation, Prolieve, Thermodilatation]
|
Abbott Completes Acquisition of Kos Pharmaceuticals, Inc.
HSMN NewsFeed,
15 Dec 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Kos Pharmaceuticals]
|
Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.
HSMN NewsFeed,
13 Dec 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Kos Pharmaceuticals]
|
Dr. Jeffrey Leiden Appointed Non Executive Director at Shire
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals, Personnel
[Shire PLC]
|
Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals
[Abbott, Enanta Pharmaceuticals, protease inhibitor, hepatitis C]
|
Vasomedical EECP(R) Therapy Provides Greater Benefit in Older Heart Failure Patients
HSMN NewsFeed,
6 Dec 2006:
Devices, Cardiology
[Vasomedical, PEECH trial, EECP, enhanced external counterpulsation]
|
Grant Life Sciences hires Kim Liao as Director of Asian Business Development
HSMN NewsFeed,
6 Dec 2006:
Diagnostics, Personnel
[Grant Life Sciences]
|
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Personnel
[Ambit Biosciences]
|
Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review
HSMN NewsFeed,
4 Dec 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Kos Pharmaceuticals]
|
Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia
HSMN NewsFeed,
4 Dec 2006:
Diagnostics, Oncology
[Abbott, Vysis, fluorescence in situ hybridization]
|
CytoCore Moves into High Gear for Product Launch with New CEO
HSMN NewsFeed,
21 Nov 2006:
Diagnostics, Oncology, Personnel
[CytoCore]
|
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
HSMN NewsFeed,
14 Nov 2006:
Diagnostics, Personnel
[Digene]
|
Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc.
HSMN NewsFeed,
14 Nov 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Kos Pharmaceuticals]
|
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis
HSMN NewsFeed,
14 Nov 2006:
Biopharmaceuticals, FDA
[Abbott, HUMIRA, adalimumab, psoriatic arthritis]
|
Interim Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals, HIV/AIDS
[Roche , INVIRASE , protease inhibitor, antiretroviral]
|
Volcano Announces Clinical Review of Key Presentations From TCT 2006
HSMN NewsFeed,
13 Nov 2006:
Devices, Interventional Cardiology
[Volcano, IVUS]
|
Use of Hyperthermia Therapy in Treating Primary and Recurrent Breast Cancer Highlights Breast Cancer Congress
HSMN NewsFeed,
8 Nov 2006:
Devices, Oncology
[BSD Medical, hyperthermia, breast cancer]
|
Napo Pharmaceuticals, Inc. ("Napo" or "the Company") Appointment of VP Clinical Affairs and Chief Medical Officer
HSMN NewsFeed,
8 Nov 2006:
Biopharmaceuticals, Personnel
[Napo Pharmaceuticals]
|
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Kos Pharmaceuticals]
|
Schering-Plough Appoints Eduardo Cortes General Manager, Argentina
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Personnel
[Schering-Plough]
|
STAAR Surgical Expands Sales and Regulatory/Quality Assurance Teams
HSMN NewsFeed,
27 Oct 2006:
Devices, Ophthalmology, Personnel
[STAAR Surgical]
|
Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals, Gastroenterology, FDA
[Abbott, HUMIRA, adalimumab, Crohn's Disease]
|
Royalty Pharma Announces Agreement Regarding the Purchase of the Rights to a Pre-Existing Royalty Interest in HUMIRA(R) From AstraZeneca and CAT
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals
[Royalty Pharma, Abbott, AstraZeneca, HUMIRA, adalimumab]
|
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
HSMN NewsFeed,
25 Oct 2006:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS ATLAS, TAXUS Liberte, drug eluting stent]
|
Data in Complex Patients and Lesions from OLYMPIA Registry Support Safety and Efficacy of TAXUS(R) Liberte(TM) Stent System
HSMN NewsFeed,
25 Oct 2006:
Devices, Interventional Cardiology
[Boston Scientific, TAXUS OLYMPIA registry, TAXUS Liberte, drug eluting stent]
|
Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent
HSMN NewsFeed,
24 Oct 2006:
Devices, Interventional Cardiology
[Abbott, Bioabsorbable Stent, drug eluting stent, coronary stent]
|
Cordis to Study Impact of Contributing Factors to Stent Thrombosis in Expansion of 30,000-Stent Patient Registry
HSMN NewsFeed,
24 Oct 2006:
Devices, Interventional Cardiology
[Cordis, Johnson & Johnson, stent thrombosis, CYPHER, drug eluting stent]
|
New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost Response to, or Were Intolerant to, Remicade(R) (Infliximab)
HSMN NewsFeed,
23 Oct 2006:
Biopharmaceuticals, Gastroenterology
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Abbott Signs Exclusive Worldwide Distribution Agreement With Verax Biomedical for Rapid Platelet Bacteria Test
HSMN NewsFeed,
20 Oct 2006:
Diagnostics, Distribution
[Abbott, Verax Biomedical, Platelet PGD Test]
|
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
HSMN NewsFeed,
18 Oct 2006:
Devices, Interventional Cardiology
[Boston Scientific, drug eluting stent, TAXUS]
|
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
HSMN NewsFeed,
17 Oct 2006:
Devices, Interventional Cardiology
[Abbott, ABSORB trial, SPIRIT II, XIENCE V, ZOMAXX, CAPTURE trial]
|
Boston Scientific Becomes only Company with Two Drug-Eluting Stent Platforms With European Approval of Everolimus-Eluting PROMUS(TM) Stent System
HSMN NewsFeed,
16 Oct 2006:
Devices, Interventional Cardiology, Regulatory
[Boston Scientific, PROMUS , drug eluting stent, Everolimus, coronary stent]
|
New Phase III Data Show Abbott's HUMIRA(R) (Adalimumab) Was Statistically Superior to Methotrexate in Patients With Psoriasis
HSMN NewsFeed,
5 Oct 2006:
Biopharmaceuticals
[Abbott, HUMIRA, adalimumab, Methotrexate, psoriasis]
|
Tracy Lawhon, J.D., Joins Cabrellis Pharmaceuticals as Vice President, Regulatory Affairs and Development Operations
HSMN NewsFeed,
5 Oct 2006:
Biopharmaceuticals, Personnel
[Cabrellis Pharmaceuticals]
|
Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
HSMN NewsFeed,
3 Oct 2006:
Devices, Interventional Cardiology
[Abbott, XIENCE V, drug eluting stent]
|
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
HSMN NewsFeed,
2 Oct 2006:
Biopharmaceuticals, Regulatory
[Ipsen, Teijin Pharma, febuxostat, Hyperuricaemia, gout]
|
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
HSMN NewsFeed,
29 Sep 2006:
Devices, Diagnostics, Endocrinology
[Abbott, Becton Dickinson, Logic meters, FreeStyle, diabetes]
|
TAP Enters Into Co-Promotion Agreement for Famvir(R)
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals
[TAP Pharmaceutical, Novartis, Famvir, famciclovir, genital herpes]
|
GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, HIV/AIDS
[GlaxoSmithKline, LEXIVA, ritonavir, LEXIVA/r, protease inhibitor]
|
Celera Identifies FCAR Genetic Polymorphism Associated with Increased Risk for Myocardial Infarction
HSMN NewsFeed,
28 Sep 2006:
Cardiology
[Celera Genomics, Applera, FCAR, myocardial infarction, CARE study]
|
Kyphon Expands Executive Management Team
HSMN NewsFeed,
18 Sep 2006:
Devices, Orthopaedic, Neurosurgery, Personnel
[Kyphon]
|
Anacor Expands Clinical Development Team
HSMN NewsFeed,
18 Sep 2006:
Biopharmaceuticals, Personnel
[Anacor Pharmaceuticals]
|
FoxHollow Technologies Increases Depth of Management Team With Two Senior Vice Presidents
HSMN NewsFeed,
18 Sep 2006:
Devices, Interventional, Personnel
[FoxHollow Technologies]
|
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
HSMN NewsFeed,
17 Sep 2006:
Biopharmaceuticals
[GlaxoSmithKline, Roche , Boniva, ibandronate, osteoporosis]
|
One in Three Parents Surveyed Unaware of Easy Ketone Test That May Help Prevent the Onset of Diabetic Ketoacidosis (DKA)
HSMN NewsFeed,
13 Sep 2006:
Diagnostics, Endocrinology
[Abbott, Diabetic Ketoacidosis, diabetic coma, blood ketone test]
|
Abbott Announces European Launch of Next-Generation Device Designed to Treat Patients at Risk of Stroke
HSMN NewsFeed,
13 Sep 2006:
Devices, Interventional
[Abbott, Abbott Vascular, embolic protection, Emboshield PRO]
|
First Patient Enrolled in First U.S. Study of Stent Placement to Treat Blockages Below the Knee
HSMN NewsFeed,
12 Sep 2006:
Devices, Interventional
[Abbott, Abbott Vascular, Xpert, self-expanding stent]
|
Sirtris Pharmaceuticals Hires Mike Jirousek as SVP of Research
HSMN NewsFeed,
12 Sep 2006:
Biopharmaceuticals, Personnel
[Sirtris Pharmaceuticals]
|
Abbott Announces Continued Expansion of Vascular Operations in Ireland to Prepare for Drug Eluting Stent Manufacturing
HSMN NewsFeed,
12 Sep 2006:
Devices, Interventional Cardiology
[Abbott, Abbott Vascular, XIENCE V]
|
Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent
HSMN NewsFeed,
8 Sep 2006:
Diagnostics, Litigation
[Innogenetics, Abbott Laboratories, Hepatitis C]
|
Hospira Announces New Contract With HealthTrust to Provide Pain Management Infusion Pumps to Members
HSMN NewsFeed,
7 Sep 2006:
Devices, Group Purchasing
[Hospira, HealthTrust Purchasing Group, pain management, infusion pump]
|
Abbott Submits U.S. and E.U. Regulatory Applications Seeking Approval for HUMIRA(R) (Adalimumab) as a Treatment for Crohn's Disease
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Gastroenterology, FDA
[Abbott, HUMIRA, adalimumab, Crohn's disease]
|
Metastatix Completes Series a Financing
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Venture Capital
[H.I.G. Ventures, Metastatix]
|
SPIRIT II Results Highlight Strength of Boston Scientific Stent Portfolio
HSMN NewsFeed,
5 Sep 2006:
Devices, Interventional Cardiology
[Boston Scientific, Abbott, SPIRIT II, TAXUS, XIENCE V]
|
Abbott's XIENCE V(TM) Drug-Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT II Clinical Trial
HSMN NewsFeed,
5 Sep 2006:
Devices, Interventional Cardiology
[Abbott, Abbott Vascular, XIENCE V, SPIRIT II, drug eluting stent]
|
PROMUS(TM) Everolimus-Eluting Stent Added to Boston Scientific Coronary Stent Portfolio
HSMN NewsFeed,
1 Sep 2006:
Devices, Interventional Cardiology
[Boston Scientific, PROMUS , drug eluting stent, Everolimus]
|
Abbott Announces Completion of Enrollment in Groundbreaking Vulnerable Plaque Study
HSMN NewsFeed,
30 Aug 2006:
Devices, Interventional Cardiology
[Abbott, Abbott Vascular, vulnerable plaque, PROSPECT study]
|
Abbott Northwestern Partners with Regional Hospitals to Improve Recognition and Treatment of Aortic Dissections
HSMN NewsFeed,
28 Aug 2006:
Cardiology
[Aortic Dissection]
|
Prestwick Pharmaceuticals Appoints George F. Horner III as President and Chief Executive Officer
HSMN NewsFeed,
22 Aug 2006:
Biopharmaceuticals, Personnel
[Prestwick Pharmaceuticals]
|
Abbott Enrolls First Patient in New Clinical Trial of XIENCE(TM) V Drug Eluting Stent
HSMN NewsFeed,
14 Aug 2006:
Devices, Interventional Cardiology
[Abbott, Abbott Vascular, SPIRIT IV, XIENCE V, drug eluting stent]
|
Oscient Pharmaceuticals and Abbott Canada Enter into Commercialization Agreement for FACTIVE Tablets
HSMN NewsFeed,
10 Aug 2006:
Biopharmaceuticals
[Oscient Pharmaceuticals, FACTIVE, gemifloxacin, Abbott Canada]
|
Dr. Tony Chou Joins The Vertical Group
HSMN NewsFeed,
1 Aug 2006:
Devices, Venture Capital, Personnel
[The Vertical Group]
|
|
|
 |
Additional items found:
The Network Archive contains
500 additional items
matching: Abbott
<< Members - click the icon at left to display. |
|
| |
|
|
|
|
Public
Feeds 
Full text >>